4/9
08:09 am
elev
Elevation Oncology, Inc. (NASDAQ: ELEV) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
Low
Report
Elevation Oncology, Inc. (NASDAQ: ELEV) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
3/7
10:23 am
elev
Elevation Oncology, Inc. (NASDAQ: ELEV) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $7.00 price target on the stock.
Medium
Report
Elevation Oncology, Inc. (NASDAQ: ELEV) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $7.00 price target on the stock.
3/7
10:23 am
elev
Elevation Oncology, Inc. (NASDAQ: ELEV) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $7.00 price target on the stock.
Medium
Report
Elevation Oncology, Inc. (NASDAQ: ELEV) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $7.00 price target on the stock.
3/7
10:02 am
elev
Rating for ELEV
High
Report
Rating for ELEV
3/7
10:02 am
elev
Rating for ELEV
High
Report
Rating for ELEV
3/7
08:14 am
elev
Rating for ELEV
Medium
Report
Rating for ELEV
3/7
08:14 am
elev
Rating for ELEV
Medium
Report
Rating for ELEV
3/1
11:35 am
elev
Rating for ELEV
Low
Report
Rating for ELEV
3/1
11:35 am
elev
Rating for ELEV
Low
Report
Rating for ELEV
3/1
08:09 am
elev
Elevation Oncology, Inc. (NASDAQ: ELEV) is now covered by analysts at JMP Securities. They set an "outperform" rating and a $7.00 price target on the stock.
High
Report
Elevation Oncology, Inc. (NASDAQ: ELEV) is now covered by analysts at JMP Securities. They set an "outperform" rating and a $7.00 price target on the stock.
3/1
08:09 am
elev
Elevation Oncology, Inc. (NASDAQ: ELEV) is now covered by analysts at JMP Securities. They set an "outperform" rating and a $7.00 price target on the stock.
High
Report
Elevation Oncology, Inc. (NASDAQ: ELEV) is now covered by analysts at JMP Securities. They set an "outperform" rating and a $7.00 price target on the stock.